Philippines Pharma and Healthcare Sector Report 2023-2024

The healthcare system in the Philippines comprises public and private components. Public healthcare in the Philippines is devolved to local government units, while the central government operates only a few tertiary care and specialist health facilities. Healthcare devolution in the Philippines has contributed to fragmentation, with significant disparities in the quality and availability of care between regions. Persistent underfunding means that the private healthcare system has been driving growth in healthcare capacity over the past few years. The government passed the Universal Health Care Act in 2019 to extend public-funded health insurance to all Filipinos, likely spurring demand for new healthcare facilities and equipment.

This report provides a complete and detailed analysis of the "Healthcare and pharma" sector for Philippines. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the "Healthcare and pharma" sector in Philippines
• Crystallise the forces both driving and restraining this sector in Philippines
• Ascertain Philippines’s position in the global sector
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in Philippines.
• Build a clear picture of trends, output and consumption for specific sub-sectors